Enveric Biosciences, Inc. ENVB
Set alert
1.45 USD +0.02 +1.40%
At close · Nov 2
1.43 -0.02 -1.38%
After hours · Nov 2, 4:00 PM ET
1.41 Day range 1.54
1.17 52-week range 13.25
- YTD
- -60.06%
- 1 year
- -74.56%
- Open
- 1.41
- Prev close
- 1.43
- Mkt cap
- 6.49M
- Vol
- 28.84K
- Avg vol
- 85.28K
- EPS
- -13.01
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.41
- High
- 1.54
- Forward P/E
- -0.22
- Beta
- 0.47
- Short ratio
- 0.31
- Inst. own
- 7.06%
- Dividend
- 0.00
- Ex-div date
- Apr 22, 2008
- 50-d avg
- 0.40876
- 200-d avg
- 0.63229
- 1y target
- 0.00
1D chart
Signals (16)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | 1:29 PM | 12 hours ago |
| MACD: Sell Signal | 1:17 PM | 12 hours ago |
| RSI: Oversold | 1:17 PM | 12 hours ago |
| MACD: Buy Signal | 1:08 PM | 13 hours ago |
| MACD: Sell Signal | 12:49 PM | 13 hours ago |
| SMA: Bullish | 12:35 PM | 13 hours ago |
| SMA: Bullish | 12:35 PM | 13 hours ago |
| MACD: Buy Signal | 12:35 PM | 13 hours ago |
| RSI: Overbought | 12:35 PM | 13 hours ago |
| RSI: Oversold | 12:34 PM | 13 hours ago |
| MACD: Sell Signal | 11:38 AM | 14 hours ago |
| MACD: Buy Signal | 11:24 AM | 14 hours ago |
| RSI: Overbought | 11:24 AM | 14 hours ago |
| MACD: Sell Signal | 10:29 AM | 15 hours ago |
| MACD: Buy Signal | 10:18 AM | 15 hours ago |
| RSI: Overbought | 9:45 AM | 16 hours ago |
Financial health
Altman Z-Score
-16.34 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2016 5y median -2.4× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016 5y median 4.4× FY 2025
P/FCF -0.1×
FY 2016 5y median -3.0× FY 2025
EV/EBITDA 0.4×
FY 2016 5y median -2.4× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -670.1%
FY 2016 5y median -33.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -290.4%
FY 2016 5y median -219.6% FY 2025
ROIC -210.0%
FY 2016 5y median -210.0% FY 2025
ROA -238.1%
FY 2016 5y median -183.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 8.9%
FY 2016 FY 2025
EPS (diluted) 84.1%
FY 2016 FY 2025
Free Cash Flow -5.4%
FY 2016 FY 2025
Financial Health
Current Ratio 5.4×
FY 2016 5y median 4.6× FY 2025
Quick Ratio 5.4×
FY 2016 5y median 4.6× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -82778×
FY 2016 5y median -3803× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
